In one of the largest recent investments in biopharmaceutical manufacturing in the U.S., global oncology company BeiGene has completed its $800 million, 400,000-square-foot biologics manufacturing and clinical development center in Hopewell, N.J. The campus is BeiGene’s U.S. flagship facility and its first U.S. manufacturing site. Source: Commercial Search 22/1/2025